Ephrem Chin

1.1k total citations
16 papers, 431 citations indexed

About

Ephrem Chin is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Ephrem Chin has authored 16 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Genetics and 3 papers in Immunology. Recurrent topics in Ephrem Chin's work include Genomic variations and chromosomal abnormalities (6 papers), Genomics and Rare Diseases (4 papers) and RNA modifications and cancer (3 papers). Ephrem Chin is often cited by papers focused on Genomic variations and chromosomal abnormalities (6 papers), Genomics and Rare Diseases (4 papers) and RNA modifications and cancer (3 papers). Ephrem Chin collaborates with scholars based in United States and Malaysia. Ephrem Chin's co-authors include Madhuri Hegde, Cristina da Silva, Shruti Bhide, Devin Rhodenizer, Bradford Coffee, Michael E. Zwick, David T. Okou, Jennifer G. Mullé, Lora Jh Bean and Stephen T. Warren and has published in prestigious journals such as Blood, The Journal of Immunology and The American Journal of Human Genetics.

In The Last Decade

Ephrem Chin

16 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ephrem Chin United States 10 256 155 55 49 42 16 431
Ji Yoo Kim Japan 9 321 1.3× 62 0.4× 32 0.6× 88 1.8× 29 0.7× 13 446
Barry L. Barnoski United States 10 422 1.6× 132 0.9× 22 0.4× 44 0.9× 18 0.4× 16 568
Tamina Seeger‐Nukpezah Germany 12 413 1.6× 373 2.4× 46 0.8× 28 0.6× 18 0.4× 19 605
Marlinde L. van den Boogaard Netherlands 11 290 1.1× 58 0.4× 40 0.7× 42 0.9× 72 1.7× 17 392
Gavin R. Oliver United States 13 316 1.2× 127 0.8× 107 1.9× 25 0.5× 18 0.4× 31 496
Stuart G. Beattie Spain 10 640 2.5× 306 2.0× 32 0.6× 36 0.7× 43 1.0× 16 797
Jinsuk Kang United States 12 616 2.4× 91 0.6× 90 1.6× 70 1.4× 15 0.4× 14 734
HA Drabkin United States 11 436 1.7× 99 0.6× 37 0.7× 47 1.0× 37 0.9× 16 582
Scott C. Crable United States 12 446 1.7× 111 0.7× 37 0.7× 46 0.9× 124 3.0× 15 572
Donatella Montanaro Italy 10 191 0.7× 55 0.4× 72 1.3× 40 0.8× 25 0.6× 15 336

Countries citing papers authored by Ephrem Chin

Since Specialization
Citations

This map shows the geographic impact of Ephrem Chin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ephrem Chin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ephrem Chin more than expected).

Fields of papers citing papers by Ephrem Chin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ephrem Chin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ephrem Chin. The network helps show where Ephrem Chin may publish in the future.

Co-authorship network of co-authors of Ephrem Chin

This figure shows the co-authorship network connecting the top 25 collaborators of Ephrem Chin. A scholar is included among the top collaborators of Ephrem Chin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ephrem Chin. Ephrem Chin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Liu, Ruby, Yinghong Pan, Lora Jh Bean, et al.. (2023). Evidence from 2100 index cases supports genome sequencing as a first-tier genetic test. Genetics in Medicine. 26(1). 100995–100995. 10 indexed citations
2.
Balciuniene, Jorune, Ruby Liu, Lora Jh Bean, et al.. (2023). At-Risk Genomic Findings for Pediatric-Onset Disorders From Genome Sequencing vs Medically Actionable Gene Panel in Proactive Screening of Newborns and Children. JAMA Network Open. 6(7). e2326445–e2326445. 8 indexed citations
3.
Görmüş, Uzay, Alka Chaubey, Suresh Shenoy, et al.. (2021). Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology. Current Issues in Molecular Biology. 43(2). 958–964. 9 indexed citations
4.
Chin, Ephrem, et al.. (2016). Optimizing Array Design and Content for the Modern Cytogenetic Research Lab. Cancer Genetics. 209(5). 246–246. 1 indexed citations
5.
Chin, Ephrem, Cristina da Silva, & Madhuri Hegde. (2013). Assessment of clinical analytical sensitivity and specificity of next-generation sequencing for detection of simple and complex mutations. BMC Genetics. 14(1). 6–6. 72 indexed citations
6.
Askree, S. Hussain, Ephrem Chin, Lora Bean, et al.. (2013). Detection limit of intragenic deletions with targeted array comparative genomic hybridization. BMC Genetics. 14(1). 116–116. 14 indexed citations
7.
Valencia, C. Alexander, Devin Rhodenizer, Shruti Bhide, et al.. (2012). Assessment of Target Enrichment Platforms Using Massively Parallel Sequencing for the Mutation Detection for Congenital Muscular Dystrophy. Journal of Molecular Diagnostics. 14(3). 233–246. 38 indexed citations
8.
Tanner, Alice, Ephrem Chin, Patricia K. Duffner, & Madhuri Hegde. (2012). Array CGH improves detection of mutations in the GALC gene associated with Krabbe disease. Orphanet Journal of Rare Diseases. 7(1). 38–38. 4 indexed citations
9.
Jones, Melanie A., Shruti Bhide, Ephrem Chin, et al.. (2012). DDOST Mutations Identified by Whole-Exome Sequencing Are Implicated in Congenital Disorders of Glycosylation. The American Journal of Human Genetics. 90(2). 363–368. 52 indexed citations
10.
Bellissimo, Daniel B., Ephrem Chin, Madhuri Hegde, et al.. (2011). Detection of VWF Copy Number Variations by Microarray Analysis in Von Willebrand Disease Type 3 Index Cases. Blood. 118(21). 380–380. 3 indexed citations
11.
Jones, Melanie A., Shruti Bhide, Ephrem Chin, et al.. (2011). Targeted polymerase chain reaction-based enrichment and next generation sequencing for diagnostic testing of congenital disorders of glycosylation. Genetics in Medicine. 13(11). 921–932. 68 indexed citations
12.
Hjelm, Lawrence N., Ephrem Chin, Madhuri Hegde, Bradford Coffee, & Lora Jh Bean. (2010). A Simple Method to Confirm and Size Deletion, Duplication, and Insertion Mutations Detected by Sequence Analysis. Journal of Molecular Diagnostics. 12(5). 607–610. 7 indexed citations
13.
Chin, Ephrem, Lora Jh Bean, Bradford Coffee, & Madhuri Hegde. (2009). Novel human pathological mutations. Human Genetics. 126(2). 329–352. 20 indexed citations
14.
Tayeh, Marwan K., Ephrem Chin, Vanessa Rangel Miller, et al.. (2009). Targeted comparative genomic hybridization array for the detection of single- and multiexon gene deletions and duplications. Genetics in Medicine. 11(4). 232–240. 32 indexed citations
15.
Hegde, Madhuri, Ephrem Chin, Jennifer G. Mullé, et al.. (2008). Microarray-based mutation detection in thedystrophingene. Human Mutation. 29(9). 1091–1099. 75 indexed citations
16.
Weisbart, Richard H., Andrew L. Wong, Amelia Kacena, et al.. (1991). The rheumatoid factor reactivity of a human IgG monoclonal autoantibody is encoded by a variant V kappa II L chain gene. The Journal of Immunology. 147(8). 2795–2801. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026